Peregrine Pharma (PPHM) Reports In-Line Q3 Loss of 13c/Share
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Selling, general and administrative: 5.06M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative: 5.06M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) reported Q3 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $3.28 million versus the consensus estimate of $2.12 million.
For earnings history and earnings-related data on Peregrine Pharmaceuticals, Inc. (PPHM) click here.
For earnings history and earnings-related data on Peregrine Pharmaceuticals, Inc. (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Activist investors push Seer, Inc. to disclose go-private timeline
- Ideal Power (IPWR) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
